| Name | Title | Contact Details |
|---|
ProHEALTH is a dynamic and growing healthcare organization, offering a wide range of employment opportunities. As we continue to grow we continually seek qualified, professional, dedicated individuals to join our team. As the largest private
EyeCare Services Partners (ESP) provides ownership and practice management of ophthalmologic, optometric and ambulatory surgery centers nationwide. ESP offers eye care providers and ambulatory surgery center owners compelling and effective solutions for today`s constantly changing healthcare environment. Utilization of our resources and expertise eliminates the stress of practice management. We are creating the nation`s leading eyecare services company in both quality and scale by consolidating ophthalmologic and optometric practices and ambulatory surgery centers that are locally dominant and clinically differentiated. We provide a patient centric model that delivers outstanding care and quality outcomes through our providers and staff by leveraging our comprehensive array of best-in-class technology, processes and managerial infrastructure.
QD Healthcare Group is a Greenwich, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Lifeblood opens the East Donor Center on Estate Drive. In 1954, another proposal to establish a blood center in Memphis was rejected for the same reason-it was too costly. Finally in 1962, the Committee on Blood Bank Operation of the Memphis and Shelby